The article focuses on a study on the development of an artificial intelligence (AI), called the AlphaFold neural network, by British AI company DeepMind, which can map the structure of 98.5 percent of human proteins, published in an issue of "Nature". Topics discussed include the implications of the study for drug development and the challenge in determining the structure of proteins based on the sequences of amino acids.